Defibrillators news | Breaking defibrillators news

News

Advertisers:

Boston Scientific St. Paul plant cleared by FDA

... Jim Tobin, CEO of Boston Scientific, said in a press release, "the improvements made to our CRM quality system demonstrate our ongoing commitment to deliver the highest quality products to physicians and the patients they serve." The FDA was originally issued to the Guidant Corp.

on December 22, 2005; Boston Scientific acquired Guidant last year.

cwyant@bizjournals.com | (612) 288-2108 Contact the Editor Need Assistance?

More Latest News Subscribe or renew online ExtraHot metros for college gradsOur study finds the best job markets for young adults • 10 hottest job markets for young adults• How largest metros rank for college grads• Poll: Does it matter what you studied?

Related Industry stories Company seeks to expand market for mental health patch as sales depressed [Tampa Bay] Beacon using titanium implant to treat narrowing of spine [Cincinnati] City in running for $300M drug plant [Birmingham] Acorn will try again for FDA approval of device [Minneapolis / St.

Paul] Greg Chiklis: Taking a shot at the flu [Boston] Related Company stories Boston Scientific gets FDA clearance on Guidant plant [Boston] Filings reveal oddities of exec pay [Boston] FDA confirms Boston Scientific defibrillator recall [Boston] Today's Latest News Stories Court rules against NWA flight attendants Summit, Schell named to brewery list Best Buy CEO exercises stock options Rural Cellular stock jumps on news of revenue growth KSTC reports record viewing for Wild play...